ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Romosozumab Versus Denosumab in Glucocorticoid-induced Osteoporosis: an Extended Observation of a Randomized Controlled Trial at 48 Months

Tuen Mun Hospital · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
fractureglucocorticoidsosteoporosisoutcome
osteoporosis, glucocorticoids toxicity, glucocorticoids, fracture, romosozumab, denosoumab, outcome, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 995588
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.